Medical News

RSS

Alcon signs definitive agreement to acquire LenSx Lasers

Alcon, Inc. announced today that it has entered into a definitive agreement to acquire LenSx Lasers, Inc, a privately held company that developed the first femtosecond laser to receive U.S. Food and Drug Administration clearance for use as a part of cataract surgery. The LenSx system is indicated for anterior capsulotomy and laser phacofragmentation during cataract surgery, providing a complementary surgical approach to certain manual steps within the traditional cataract procedure.

7 Jul 2010

FDA grants Angion Biomedica's BB3 therapeutic Fast Track and Orphan Drug product designations

Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.

7 Jul 2010

POMC neurons suppress appetite, induce weight loss: Research

A protein found in cells throughout the body must be present in a specific set of neurons in the brain to prevent weight gain after chronic feeding on high-calorie meals, new findings from UT Southwestern Medical Center researchers suggest.

7 Jul 2010

Some state insurance commissioners push back on Fed premium rate reviews

Politico: Some state insurance commissioners are not happy with a proposal that would give the federal government the authority to centralize premium rate reviews of health insurance.

7 Jul 2010

Questions surround Republican leaders' level of support for health reform repeal efforts

The Hill: Some Republican leaders may not be fully embracing a Senate bill aimed at repealing the health reform overhaul despite other GOP endorsements. "Senate Minority Leader Mitch McConnell (Ky.), GOP Conference Chair Lamar Alexander (Tenn.) and Conference Vice Chair Lisa Murkowski (Alaska) have all argued that the reforms — passed in March without Republican support — will hike costs and erode services, and therefore should be scrapped.

7 Jul 2010

Obama and High Court at odds; Health law could be at stake

The Los Angeles Times explores the "deep divide" between President Barack Obama's administration and the Supreme Court under Chief Justice John Roberts. "The president and congressional Democrats have embarked on an ambitious drive to regulate corporations, banks, health insurers and the energy industry.

7 Jul 2010

AIDS Healthcare Foundation presses Obama Administration on PEPFAR funding

The AIDS Healthcare Foundation (AHF), "[t]he largest global AIDS organization[,] accused the Obama administration and Congress on Friday of falling short on promised funding and oversight in the worldwide fight against the epidemic," The Hill's "Healthwatch" blog reports.

7 Jul 2010

Debate over the ill effects of wind turbines on health

The National Health and Medical Research Council (NHMRC) studied the purported ill effects of the wind turbines on health before reporting that there was no evidence that the turbines' low frequency noise or shadow flicker made people ill.

6 Jul 2010

Bacteria that will kill Dengue bearing mosquitoes on the way

Dengue is a deadly viral fever spread by mosquito bites that kills thousands around the world each year. Now researchers from James Cook University and University of Queensland are working on a bacterium called Wolbachia that can stop the spread of this virus.

6 Jul 2010

Payroll woes may spread to other systems if incorporated: Auditor General’s report

There have been massive errors in the newly introduced payroll system of the Queensland health care staff since March this year. It left many workers under, over or un-paid for weeks.

6 Jul 2010

Cornerstone reacquires all development, commercial rights to HMGB1 related technology from MedImmune

Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has reacquired all development and commercial rights to its high-mobility group box protein 1 (HMGB1) related technology from MedImmune, LLC.

6 Jul 2010

Three Rivers Pharmaceuticals receives FDA expanded labeling for INFERGEN

Three Rivers Pharmaceuticals, LLC, today received expanded labeling from the U.S. Food and Drug Administration (FDA) to include daily use of INFERGEN (Consensus Interferon) in combination with ribavirin (RBV) for retreatment of chronic hepatitis C patients. The expanded labeling targets hepatitis C patients who need retreatment.

6 Jul 2010

Preclinical efficacy data of Sangamo's ZFN based human stem cell therapy for HIV published

Sangamo BioSciences, Inc. announced the publication of data demonstrating the preclinical efficacy of a human stem cell therapy for human immunodeficiency virus (HIV) based on its proprietary zinc finger DNA-binding protein nuclease (ZFN) technology.

6 Jul 2010

Epworth Manor celebrates 90 years of community care on July 8, 2010

From its humble beginnings in 1919 as a home for 14 residents, to the now seven-acre campus housing and caring for up to 172 seniors, Epworth Manor will be celebrating 90 years of being part of the Tyrone and central Pennsylvania community. An outdoor celebration will take place on July 8, from 5:30 p.m. to 7:30 p.m. and will include a big band concert by the Hallmark's, refreshments, photographs and memorabilia. The celebration will take place on the Epworth campus located at 951 Washington Ave., Tyrone, Pa.

6 Jul 2010

IRIS wins Premier healthcare alliance's fifth annual Pinnacle Award

IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it is the winner of the fifth annual Pinnacle Award presented by the Premier healthcare alliance.

6 Jul 2010

CPRIT grants RBM $3 million Company Commercialization Award to expand OncologyMAP program

Rules-Based Medicine, Inc. (RBM) today announced the Cancer Prevention and Research Institute of Texas (CPRIT) has granted it a Company Commercialization Award to expand and enhance the OncologyMAP™ program for discovery and development of novel diagnostic and prognostic cancer tests. The award of approximately $3 million will fund research and development to more than double the number of cancer-associated biomarker assays in RBM's new OncologyMAP™ product.

6 Jul 2010

HTDS, Shenzhen Mellow Hope secure new business partner in Ethiopia

Hard to Treat Diseases, Inc. and Shenzhen Mellow Hope are excited to announce that the company has secured a new business partner in Ethiopia through which Mellow Hope will distribute biomedical vaccines.

6 Jul 2010

BioNeutral, KRP complete manufacturing and distribution agreement

BioNeutral Group Inc., a specialty chemical technology-based life science company, announced today that it completed an agreement with Keystone Research and Pharmaceuticals for its proprietary formulations for use in the Veterinary, Dental and Cosmetic markets. The Terms are being held confidential.

6 Jul 2010

Certeon expands international distribution capabilities with CDG partnership

Certeon, the leading provider of virtualized software-based WAN optimization and application acceleration, today announced it has signed a distribution agreement with CDG, a major distributor of leading-edge information technology in the United Kingdom and throughout Europe. CDG specializes in the most innovative technologies for the WAN acceleration and cloud computing markets.

6 Jul 2010

Amorfix partners with reMYND to offer A4 amyloid testing services

Amorfix Life Sciences Ltd. and reMYND NV today announced the signing of a partnership agreement to offer the Amorfix A4 amyloid testing service to reMYND's contract research clients. reMYND's contract research business offers an extensive portfolio of preclinical in-vivo efficacy, pharmacokinetic and safety testing of experimental Alzheimer therapies using proprietary mouse models of Alzheimer's disease (AD).

6 Jul 2010